MNA
NVS icon

Manning & Napier Advisors’s Novartis NVS Stock Holding History

Manning & Napier Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
73,973
-10,970
-13% -$1.64M 0.15% 86
2026
Q1 		$13M Sell
84,943
-909
-1% -$139K 0.18% 88
2025
Q4 		$11.9M Sell
85,852
-2,626
-3% -$344K 0.15% 84
2025
Q3 		$11.3M Sell
88,478
-7,437
-8% -$907K 0.14% 83
2025
Q2 		$11.6M Sell
95,915
-37,393
-28% -$4.21M 0.14% 108
2025
Q1 		$14.9M Sell
133,308
-3,590
-3% -$382K 0.18% 89
2024
Q4 		$13.3M Sell
136,898
-4,865
-3% -$519K 0.15% 97
2024
Q3 		$16.3M Buy
141,763
+449
+0.3% +$50.9K 0.18% 92
2024
Q2 		$15M Buy
+141,314
New +$14.2M 0.17% 99
2017
Q3 		$377M Sell
4,902,207
-418,572
-8% -$31.6M 3.23% 3
2017
Q2 		$398M Sell
5,320,779
-261,588
-5% -$18.5M 3.42% 2
2017
Q1 		$372M Sell
5,582,367
-615,906
-10% -$41M 2.88% 7
2016
Q4 		$405M Buy
6,198,273
+2,010,924
+48% +$130M 2.65% 9
2016
Q3 		$296M Buy
4,187,349
+209,192
+5% +$15.2M 1.82% 19
2016
Q2 		$294M Sell
3,978,157
-82,267
-2% -$5.68M 1.78% 18
2016
Q1 		$264M Buy
4,060,424
+146,125
+4% +$9.94M 1.53% 29
2015
Q4 		$302M Buy
3,914,299
+811,701
+26% +$64.5M 1.76% 18
2015
Q3 		$256M Buy
3,102,598
+1,667,084
+116% +$148M 1.37% 28
2015
Q2 		$126M Buy
1,435,514
+1,031,751
+256% +$94.7M 0.55% 56
2015
Q1 		$35.7M Buy
403,763
+3,483
+0.9% +$309K 0.17% 88
2014
Q4 		$33.2M Buy
400,280
+15,393
+4% +$1.28M 0.15% 93
2014
Q3 		$32.5M Buy
384,887
+13,589
+4% +$1.1M 0.14% 100
2014
Q2 		$30.1M Buy
371,298
+20,529
+6% +$1.61M 0.12% 103
2014
Q1 		$26.7M Sell
350,769
-50,910
-13% -$3.71M 0.11% 104
2013
Q4 		$28.9M Sell
401,679
-11,863
-3% -$825K 0.13% 94
2013
Q3 		$28.4M Buy
413,542
+4,853
+1% +$321K 0.13% 89
2013
Q2 		$25.9M Buy
+408,689
New +$26.6M 0.14% 86

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Manning & Napier Advisors's NVS Position: Q2 2026 in Review

Manning & Napier Advisors reduced its Novartis (NVS) stake by 13% in Q2 2026, selling an estimated $1.64M and leaving 73,973 shares worth $11.7M. The position accounts for 0.15% of the portfolio, ranked #86.

Manning & Napier Advisors first reported a position in NVS in Q2 2013 and has held it in 27 quarters since. The position peaked at $405M in Q4 2016. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Manning & Napier Advisors held 73,973 shares of Novartis worth $11.7M as of Q2 2026.
  • Manning & Napier Advisors sold 10,970 Novartis shares in Q2 2026, an estimated $1.64M.
  • Novartis made up 0.15% of Manning & Napier Advisors's portfolio in Q2 2026, its #86 holding.
  • Manning & Napier Advisors first reported a position in Novartis in Q2 2013 and has held it in 27 quarters since.
  • Manning & Napier Advisors's Novartis position peaked at $405M in Q4 2016.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.